The Role of Toll-Like Receptors in Osteoclastogenesis

키워드

참고문헌 (84)

1. Mone Zaidi, "Skeletal remodeling in health and disease", Nature Medicine, 13(7), pp.791~801 (2007), Springer Science and Business Media LLC[DOI]
2. G. A. Rodan, "Therapeutic Approaches to Bone Diseases", Science, 289(5484), pp.1508~1514 (2000), American Association for the Advancement of Science (AAAS)[DOI]
3. Tatsuo Suda, "Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families", Endocrine Reviews, 20(3), pp.345~357 (1999), The Endocrine Society[DOI]
4. William J. Boyle, "Osteoclast differentiation and activation", Nature, 423(6937), pp.337~342 (2003), Springer Science and Business Media LLC[DOI]
5. H Kodama, "Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells.", Journal of Experimental Medicine, 173(5), pp.1291~1294 (1991), Rockefeller University Press[DOI]
6. Dirk M. Anderson, "A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function", Nature, 390(6656), pp.175~179 (1997), Springer Science and Business Media LLC[DOI]
7. Koichi Matsuo, "Nuclear Factor of Activated T-cells (NFAT) Rescues Osteoclastogenesis in Precursors Lacking c-Fos", Journal of Biological Chemistry, 279(25), pp.26475~26480 (2004), Elsevier BV[DOI]
8. Erwin F. Wagner, "Fos", AP-1 proteins in bone and the immune system, 2005, pp.208(1), 126~140[DOI]
9. Hiroshi Takayanagi, "Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts", Developmental Cell, 3(6), pp.889~901 (2002), Elsevier BV[DOI]
10. 김정하, "Regulation of NFATc1 in Osteoclast Differentiation", 대한골대사학회지, 21(4), pp.233~241 (2014), 대한골대사학회[DOI]
11. Takako Koga, "Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis", Nature, 428(6984), pp.758~763 (2004), Springer Science and Business Media LLC[DOI]
12. A. Mocsai, "The immunomodulatory adapter proteins DAP12 and Fc receptor  -chain (FcR ) regulate development of functional osteoclasts through the Syk tyrosine kinase", Proceedings of the National Academy of Sciences, 101(16), pp.6158~6163 (2004), Proceedings of the National Academy of Sciences[DOI]
13. Ruslan Medzhitov, "Toll-like receptors and innate immunity", Nature Reviews Immunology, 1(2), pp.135~145 (2001), Springer Science and Business Media LLC[DOI]
14. Istvan Botos, "The Structural Biology of Toll-like Receptors", Structure, 19(4), pp.447~459 (2011), Elsevier BV[DOI]
15. Michael Rehli, "Of mice and men: species variations of Toll-like receptor expression", Trends in Immunology, 23(8), pp.375~378 (2002), Elsevier BV[DOI]
16. Anne F McGettrick, "Localisation and trafficking of Toll-like receptors: an important mode of regulation", Current Opinion in Immunology, 22(1), pp.20~27 (2010), Elsevier BV[DOI]
17. Rock J. Mancini, "Directing the Immune System with Chemical Compounds", ACS Chemical Biology, 9(5), pp.1075~1085 (2014), American Chemical Society (ACS)[DOI]
18. Piccinini AM, "DAMPening inflammation by modulating TLR signalling", Mediators Inflamm, 2010 (2010)[DOI]
19. Dirk Foell, "S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules", Journal of Leukocyte Biology, 81(1), pp.28~37 (2007), Wiley[DOI]
20. Allan Tsung, "HMGB1 release induced by liver ischemia involves Toll-like receptor 4–dependent reactive oxygen species production and calcium-mediated signaling", Journal of Experimental Medicine, 204(12), pp.2913~2923 (2007), Rockefeller University Press[DOI]
21. Haifeng Zhang, "Integrin-nucleated Toll-like receptor (TLR) dimerization reveals subcellular targeting of TLRs and distinct mechanisms of TLR4 activation and signaling", FEBS Letters, 532(1-2), pp.171~176 (2002), Wiley[DOI]
22. Marije Oosting, "Human TLR10 is an anti-inflammatory pattern-recognition receptor", Proceedings of the National Academy of Sciences, 111(42), pp.E4478~E4484 (2014), Proceedings of the National Academy of Sciences[DOI]
23. A. Ozinsky, "The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors", Proceedings of the National Academy of Sciences, 97(25), pp.13766~13771 (2000), Proceedings of the National Academy of Sciences[DOI]
24. Ozinsky A, "Co-operative induction of pro-inflammatory signaling by Toll-like receptors", J Endotoxin Res, 6, pp.393~396 (2000)
25. Luke A. J. O'Neill, "The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling", Nature Reviews Immunology, 7(5), pp.353~364 (2007), Springer Science and Business Media LLC[DOI]
26. M. Yamamoto, "Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway", Science, 301(5633), pp.640~643 (2003), American Association for the Advancement of Science (AAAS)[DOI]
27. Masahiro Yamamoto, "Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4", Nature, 420(6913), pp.324~329 (2002), Springer Science and Business Media LLC[DOI]
28. Luke A. J. O'Neill, "Mal and MyD88: adapter proteins involved in signal transduction by Toll-like receptors", Journal of Endotoxin Research, 9(1), pp.55~59 (2003), SAGE Publications[DOI]
29. M Yamamoto, "TIR domain-containing adaptors define the specificity of TLR signaling", Molecular Immunology, 40(12), pp.861~868 (2004), Elsevier BV[DOI]
30. O'Neill LA, "Signal transduction pathways activated by the IL-1 receptor", toll-like receptor superfamily, 2002, pp.270, 47~61
31. Neil Warner, "MyD88: A Critical Adaptor Protein in Innate Immunity Signal Transduction", The Journal of Immunology, 190(1), pp.3~4 (2012), The American Association of Immunologists[DOI]
32. J. Brown, "TLR-signaling Networks", Journal of Dental Research, 90(4), pp.417~427 (2011), SAGE Publications[DOI]
33. Masahiro Yamamoto, "Cutting Edge: A Novel Toll", IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor Signaling, 2002, pp.169(12), 6668~6672[DOI]
34. Zhengfan Jiang, "Pellino 1 Is Required for Interleukin-1 (IL-1)-mediated Signaling through Its Interaction with the IL-1 Receptor-associated Kinase 4 (IRAK4)-IRAK-Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) Complex", Journal of Biological Chemistry, 278(13), pp.10952~10956 (2003), Elsevier BV[DOI]
35. Z. Jiang, "Toll-like receptor 3-mediated activation of NF- B and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-", Proceedings of the National Academy of Sciences, 101(10), pp.3533~3538 (2004), Proceedings of the National Academy of Sciences[DOI]
36. John Hiscott, "Triggering the Innate Antiviral Response through IRF-3 Activation", Journal of Biological Chemistry, 282(21), pp.15325~15329 (2007), Elsevier BV[DOI]
37. Pengyuan Yang, "The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a β-catenin-dependent pathway", Nature Immunology, 11(6), pp.487~494 (2010), Springer Science and Business Media LLC[DOI]
38. William J. Kaiser, "Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL", Journal of Biological Chemistry, 288(43), pp.31268~31279 (2013), Elsevier BV[DOI]
39. Klaus Ruckdeschel, "Signaling of Apoptosis through TLRs Critically Involves Toll", IL-1 Receptor Domain-Containing Adapter Inducing IFN-β, but Not MyD88, in Bacteria-Infected Murine Macrophages, 2004, pp.173(5), 3320~3328[DOI]
40. Carl De Trez, "TLR4 and Toll-IL-1 receptor domain-containing adapter-inducing IFN-beta, but not MyD88, regulate Escherichia coli-induced dendritic cell maturation and apoptosis in vivo", The Journal of Immunology, 175(2), pp.839~846 (2005), The American Association of Immunologists[DOI]
41. Masamichi Takami, "Stimulation by Toll-Like Receptors Inhibits Osteoclast Differentiation", The Journal of Immunology, 169(3), pp.1516~1523 (2002), The American Association of Immunologists[DOI]
42. Zvi Bar-Shavit, "Taking a Toll on the bones: Regulation of bone metabolism by innate immune regulators", Autoimmunity, 41(3), pp.195~203 (2009), Informa UK Limited[DOI]
43. Luke AJ O'Neill, "Primer: Toll-like receptor signaling pathways—what do rheumatologists need to know?", Nature Clinical Practice Rheumatology, 4(6), pp.319~327 (2008), Springer Science and Business Media LLC[DOI]
44. Goh FG, "Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis", Rheumatology(Oxford), 51, pp.7~23 (2012)[DOI]
45. Jiménez-Dalmaroni MJ, "The critical role of toll-like receptors--From microbial recognition to autoimmunity: A comprehensive review", Autoimmunity Reviews, 15(1), pp.1~8 (2016), Elsevier BV[DOI]
46. Hatem A. Elshabrawy, "TLRs, future potential therapeutic targets for RA", Autoimmunity Reviews, 16(2), pp.103~113 (2017), Elsevier BV[DOI]
47. Pedro P. C. Souza, "Finding a Toll on the Route: The Fate of Osteoclast Progenitors After Toll-Like Receptor Activation", Frontiers in Immunology, 10 (2019), Frontiers Media SA[DOI]
48. Ping Zhang, "TLR2-dependent Modulation of Osteoclastogenesis by Porphyromonas gingivalis through Differential Induction of NFATc1 and NF-κB", Journal of Biological Chemistry, 286(27), pp.24159~24169 (2011), Elsevier BV[DOI]
49. Wei Zou, "Dual Modulation of Osteoclast Differentiation by Lipopolysaccharide", Journal of Bone and Mineral Research, 17(7), pp.1211~1218 (2002), Wiley[DOI]
50. Jianzhong Liu, "Molecular Mechanism of the Bifunctional Role of Lipopolysaccharide in Osteoclastogenesis", Journal of Biological Chemistry, 284(18), pp.12512~12523 (2009), Elsevier BV[DOI]
51. Zhihong Chen, "IL-1R", TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1), 2015, pp.290(50), 30163~30174[DOI]
52. Youngkyun Lee, "The phosphatidylinositol 3-kinase-mediated production of interferon-β is critical for the lipopolysaccharide inhibition of osteoclastogenesis", Life Sciences, 83(9-10), pp.369~376 (2008), Elsevier BV[DOI]
53. Luke AJ O’Neill, "How Toll-like receptors signal: what we know and what we don’t know", Current Opinion in Immunology, 18(1), pp.3~9 (2006), Elsevier BV[DOI]
54. Honda K, "Regulation of the type I IFN induction : a current view", Int Immunol, 17, pp.1367~1378 (2005)[DOI]
55. Hiroshi Takayanagi, "RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β", Nature, 416(6882), pp.744~749 (2002), Springer Science and Business Media LLC[DOI]
56. Hyunil Ha, "Stimulation by TLR5 Modulates Osteoclast Differentiation through STAT1", IFN-β, 2008, pp.180(3), 1382~1389[DOI]
57. Anson K. Abraham, "Mechanisms of interferon-β effects on bone homeostasis", Biochemical Pharmacology, 77(12), pp.1757~1762 (2009), Elsevier BV[DOI]
58. Koji Suda, "Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-?, IL-1, and RANKL", Journal of Cellular Physiology, 190(1), pp.101~108 (2002), Wiley[DOI]
59. Kimiko Ohgi, "Toll-like receptor 2 activation primes and upregulates osteoclastogenesis via lox-1", Lipids in Health and Disease, 17(1) (2018), Springer Science and Business Media LLC[DOI]
60. Y. Sakuma, "Impaired Bone Resorption by Lipopolysaccharide In Vivo in Mice Deficient in the Prostaglandin E Receptor EP4 Subtype", Infection and Immunity, 68(12), pp.6819~6825 (2000), American Society for Microbiology[DOI]
61. Chisato Miyaura, "An Essential Role of Cytosolic Phospholipase A2α in Prostaglandin E2–mediated Bone Resorption Associated with Inflammation", Journal of Experimental Medicine, 197(10), pp.1303~1310 (2003), Rockefeller University Press[DOI]
62. Chiho Matsumoto, "Toll-like receptor 2 heterodimers, TLR2", 6 and TLR2, Biochemical and Biophysical Research Communications, pp.2012, 428(1)[DOI]
63. K Kimura, "An anti-c-Fms antibody inhibits osteoclastogenesis in a mouse periodontitis model", Oral Diseases, 20(3), pp.319~324 (2014), Wiley[DOI]
64. Shahla Abdollahi-Roodsaz, "Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production", Arthritis & Rheumatism, 58(12), pp.3753~3764 (2008), Wiley[DOI]
65. Leo A. B. Joosten, "T cell dependence of chronic destructive murine arthritis induced by repeated local activation of toll-like receptor–driven pathways: Crucial role of both interleukin-1β and interleukin-17", Arthritis & Rheumatism, 58(1), pp.98~108 (2008), Wiley[DOI]
66. Seung-jae Kim, "Ligation of TLR5 Promotes Myeloid Cell Infiltration and Differentiation into Mature Osteoclasts in Rheumatoid Arthritis and Experimental Arthritis", The Journal of Immunology, 193(8), pp.3902~3913 (2014), The American Association of Immunologists[DOI]
67. Saba Alzabin, "Investigation of the role of endosomal Toll-like receptors in murine collagen-induced arthritis reveals a potential role for TLR7 in disease maintenance", Arthritis Research & Therapy, 14(3), pp.R142~ (2012), Springer Science and Business Media LLC[DOI]
68. Pierre Duffau, "Promotion of Inflammatory Arthritis by Interferon Regulatory Factor 5 in a Mouse Model", Arthritis & Rheumatology, 67(12), pp.3146~3157 (2015), Wiley[DOI]
69. Liesu Meng, "Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats", Arthritis Research & Therapy, 12(3), pp.R103~ (2010), Springer Science and Business Media LLC[DOI]
70. Fariba Zare, "Arthritogenic Properties of Double-Stranded (Viral) RNA", The Journal of Immunology, 172(9), pp.5656~5663 (2004), The American Association of Immunologists[DOI]
71. Anna Yarilina, "Suppression of the Effector Phase of Inflammatory Arthritis by Double-Stranded RNA Is Mediated by Type I IFNs", The Journal of Immunology, 178(4), pp.2204~2211 (2007), The American Association of Immunologists[DOI]
72. Guo-Min Deng, "Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis", Nature Medicine, 5(6), pp.702~705 (1999), Springer Science and Business Media LLC[DOI]
73. Hsin-Jung Wu, "Inflammatory arthritis can be reined in by CpG-induced DC–NK cell cross talk", Journal of Experimental Medicine, 204(8), pp.1911~1922 (2007), Rockefeller University Press[DOI]
74. Yongwon Choi, "Promising bone-related therapeutic targets for rheumatoid arthritis", Nature Reviews Rheumatology, 5(10), pp.543~548 (2009), Springer Science and Business Media LLC[DOI]
75. Kyoji Ikeda, "Factors and Mechanisms Involved in the Coupling from Bone Resorption to Formation: How Osteoclasts Talk to Osteoblasts", 대한골대사학회지, 21(3), pp.163~167 (2014), 대한골대사학회
76. Ian Marriott, "Osteoblast Responses to Bacterial Pathogens: A Previously Unappreciated Role for Bone-Forming Cells in Host Defense and Disease Progression", Immunologic Research, 30(3), pp.291~308 (2004), Springer Science and Business Media LLC[DOI]
77. Ali Kassem, "Toll-Like Receptor 2 Stimulation of Osteoblasts Mediates Staphylococcus Aureus Induced Bone Resorption and Osteoclastogenesis through Enhanced RANKL", PLOS ONE, 11(6), pp.e0156708~ (2016), Public Library of Science (PLoS)[DOI]
78. Ali Kassem, "Porphyromonas gingivalis Stimulates Bone Resorption by Enhancing RANKL (Receptor Activator of NF-κB Ligand) through Activation of Toll-like Receptor 2 in Osteoblasts", Journal of Biological Chemistry, 290(33), pp.20147~20158 (2015), Elsevier BV[DOI]
79. H. Nakamura, "Lack of Toll-like receptor 4 decreases lipopolysaccharide-induced bone resorption in C3H", HeJ mice in vivo, 2008, pp.23(3), 190~195[DOI]
80. Ali Kassem, "TLR5, a novel mediator of innate immunity‐induced osteoclastogenesis and bone loss", The FASEB Journal, 29(11), pp.4449~4460 (2015), Wiley[DOI]
81. Wei Zou, "CpG Oligodeoxynucleotides Modulate the Osteoclastogenic Activity of Osteoblasts via Toll-like Receptor 9", Journal of Biological Chemistry, 278(19), pp.16732~16740 (2003), Elsevier BV[DOI]
82. Yuichi Ishihara, "Role of interleukin-1 and prostaglandin in in vitro bone resorption induced by Actinobacillus actinomycetemcomitans lipopolysaccharide", Journal of Periodontal Research, 26(3), pp.155~160 (1991), Wiley[DOI]
83. Dana T Graves, "Osteocytes play an important role in experimental periodontitis in healthy and diabetic mice through expression of RANKL", Journal of Clinical Periodontology, 45(3), pp.285~292 (2018), Wiley[DOI]
84. Muhammad Ayaz Anwar, "Recent clinical trends in Toll‐like receptor targeting therapeutics", Medicinal Research Reviews, 39(3), pp.1053~1090 (2018), Wiley[DOI]

관련 논문AI추천